Buscar
Mostrando ítems 1-10 de 96
Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules
(Elsevier B.V., 2009-11-15)
This paper describes the optimization and validation of an analytical methodology for the determination of losartan potassium in capsules by HPLC using 2(5-1) fractional factorial and Doehlert designs. This multivariate ...
IN VITRO EVIDENCES FOR SIMVASTATIN AND LOSARTAN POTASSIUM INTERACTION AND ITS IN VIVO IMPLICATIONS
(Sociedad Chilena de Química, 2009)
A simple and precise conductometric method for the determination of losartan in pharmaceutical products
(VERSITAWARSAW, 2012)
Losartan is an antihypertensive agent that lost its patent protection in 2010, and, consequently, it has been available in generic form. The latter motivated the search for a rapid and precise alternative method. Here, a ...
Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules
(Elsevier B.V., 2009-11-15)
This paper describes the optimization and validation of an analytical methodology for the determination of losartan potassium in capsules by HPLC using 2(5-1) fractional factorial and Doehlert designs. This multivariate ...
Comparative study of analytical methods by direct and first-derivative UV spectrophotometry for evaluation of losartan potassium in capsules
(Universidade de São Paulo (USP), Faculdade de Ciências Farmacêuticas, 2014)
Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules
(Elsevier Science BvAmsterdamHolanda, 2009)
Development and validation of an UV derivative spectrophotometric determination of Losartan potassium in tablets
(PERGAMON-ELSEVIER SCIENCE LTD, 2003-09-19)
Development and validation of an analytical UV derivative spectrophotometric method to quantify Losartan potassium used as a single active principle in pharmaceutical forms were done. Pharmacopeias have not yet provided ...
Renal effects of angiotensin II receptor subtype 1 and 2-selective ligands injected into the paraventricular nucleus of conscious rats
(1999-10-22)
We determined the effects of losartan and CGP42112A (selective ligands of the AT1 and AT2 angiotensin receptors, respectively) and salarasin (a relatively nonselective angiotensin receptor antagonist) on urinary volume and ...